Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Climb Bio, Inc. | CHIEF ACCOUNTING OFFICER | Restricted Stock Units | 25K | $202K | $8.06 | Dec 18, 2024 | Direct |
Climb Bio, Inc. | CHIEF ACCOUNTING OFFICER | Common Stock | 11.3K | $22.9K | $2.02 | Dec 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLYM | Climb Bio, Inc. | Dec 18, 2024 | 3 | -$2.49K | 4 | Dec 20, 2024 | CHIEF ACCOUNTING OFFICER |
ELYM | Eliem Therapeutics, Inc. | Sep 18, 2024 | 4 | -$9.74K | 4 | Sep 20, 2024 | CHIEF ACCOUNTING OFFICER |
ELYM | Eliem Therapeutics, Inc. | Jun 18, 2024 | 3 | -$8.98K | 4 | Jun 21, 2024 | CHIEF ACCOUNTING OFFICER |
ELYM | Eliem Therapeutics, Inc. | Mar 18, 2024 | 1 | $0 | 4 | Mar 20, 2024 | CHIEF ACCOUNTING OFFICER |
ELYM | Eliem Therapeutics, Inc. | Mar 13, 2023 | 0 | $0 | 3 | Mar 21, 2023 | Chief Accounting Officer |